Citius Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Fair Value
Citius Pharmaceuticals, Inc. (CTXR) reported Adjustments to Additional Paid in Capital, Fair Value of -$1.43 million for the 9-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket · last filed 2017-08-14
- Citius Pharmaceuticals, Inc. adjustments to additional paid in capital, fair value for the quarter ending 2017-06-30 was -$620.00K.
- Citius Pharmaceuticals, Inc. adjustments to additional paid in capital, fair value for the quarter ending 2017-03-31 was -$664.11K.
- Citius Pharmaceuticals, Inc. adjustments to additional paid in capital, fair value for the quarter ending 2016-12-31 was -$149.21K.
- Citius Pharmaceuticals, Inc. adjustments to additional paid in capital, fair value for the quarter ending 2016-09-30 was -$444.11K.
- Citius Pharmaceuticals, Inc. adjustments to additional paid in capital, fair value for fiscal 2016 was -$1.09M.
- Citius Pharmaceuticals, Inc. adjustments to additional paid in capital, fair value for fiscal 2015 was -$1.15M.
| Period end | Adjustments to Additional Paid in Capital, Fair Value 3 month | Adjustments to Additional Paid in Capital, Fair Value 6 month | Adjustments to Additional Paid in Capital, Fair Value 9 month | Adjustments to Additional Paid in Capital, Fair Value 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$620.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | -$1.28M derived: sum of 2 quarters · filed 2017-08-14 | -$1.43M 10-Q · filed 2017-08-14 | -$1.88M derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | -$664.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | -$813.32K 10-Q · filed 2017-05-15 | -$1.26M derived: sum of 3 quarters · filed 2017-05-15 | -$1.79M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-12-31 | -$149.21K 10-Q · filed 2017-02-14 | -$593.32K derived: sum of 2 quarters · filed 2017-02-14 | -$1.13M derived: sum of 3 quarters · filed 2017-08-14 | |
| 2016-09-30 | -$444.11K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | -$979.46K derived: sum of 2 quarters · filed 2017-08-14 | -$1.09M 10-K · filed 2016-12-23 | |
| 2016-06-30 | -$535.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | -$649.66K 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$114.31K 10-Q · filed 2017-05-15 | |||
| 2015-09-30 | -$1.15M 10-K · filed 2016-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |